MicroRNA Expression and JAK2 Allele Burden in Bone Marrow Trephine Biopsies of Polycythemia Vera, Essential Thrombocythemia and Early Primary Myelofibrosis
Authors:
- Niklas GebauerNGNiklas Gebauer
- Veronica BernardVBVeronica Bernard
- Wolfgang GebauerWGWolfgang Gebauer
- Alfred C. FellerAFAlfred C. Feller
- Hartmut MerzHMHartmut Merz
- 19 January 2013
- journal article
- Published by S. Karger AG in Acta Haematologica
- Vol. 129 (4) , 251-256
Abstract
Background/Aims: MicroRNAs (miRNAs) play an important role in cellular differentiation and cancer pathogenesis. However, their role in promoting the malignant phenotype of myeloproliferative diseases and their importance for differential diagnosis of early-stage chronic myeloproliferative diseases (CMPDs) remains widely obscure. Methods: In this study, we systematically evaluated the differential expression of miRNAs previously described to be associated with myelopoiesis and myeloproliferative pathogenesis by quantitative RT-PCR in polycythemia vera, essential thrombocythemia, early primary myelofibrosis (PMF) and normal hematopoiesis. Our goal was to establish certain miRNAs as potential markers for CMPDs to facilitate the differentiation between these diseases and to further investigate molecular differences between the subtypes of myeloproliferative neoplasia. Results: An aberrant expression of miRNAs 10a and 150 could be demonstrated for essential thrombocythemia and PMF as well as for polycythemia vera and PMF, respectively. The expression of miR-150 could further be shown to correlate with both JAK2 allele burden and peripheral blood counts. Conclusion: Thus, the miRNAs investigated in this study seem to be potential marker oncomiRs in the differential diagnosis of CMPDs and possibly hold potential for the elucidation of a JAK2-independent mechanism of pathogenesis.Keywords
This publication has 20 references indexed in Scilit:
- A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of acute promyelocytic leukemia cellsLeukemia, 2009
- Down-Regulation of hsa-miR-10a in Chronic Myeloid Leukemia CD34+ Cells Increases USF2-Mediated Cell GrowthMolecular Cancer Research, 2008
- MicroRNA expression profile in granulocytes from primary myelofibrosis patientsExperimental Hematology, 2007
- Regulated expression of microRNAs in normal and polycythemia vera erythropoiesisExperimental Hematology, 2007
- Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia veraLeukemia, 2007
- MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysisLeukemia, 2007
- Aberrant Collagenase Expression in Chronic Idiopathic Myelofibrosis Is Related to the Stage of Disease but Not to the JAK2 Mutation StatusThe American Journal of Pathology, 2006
- Presence of JAK2 V617F tyrosine kinase mutation as a myeloid-lineage-specific mutation in chronic neutrophilic leukaemiaLeukemia, 2006
- Bone Marrow Histopathology in Myeloproliferative Disorders—Current Diagnostic ApproachSeminars in Hematology, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005